CTSV and hepatocellular carcinoma: We also discovered a natural small molecule medication that can target the lysosomal core target protein CTSV via molecular docking, and we confirmed in vitro that knocking down CTSV decreases the proliferation and invasion of hepatocellular carcinoma cell lines.